Michael Kauffman Insider Trading $KPTI Karyopharm Therapeutics Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Michael Kauffman.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Michael Kauffman. Michael Kauffman is Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Chief Executive Officer in Karyopharm Therapeutics Inc. ($KPTI) and Director in Verastem, Inc. ($VSTM) and Director in Kezar Life Sciences, Inc. ($KZR).

Michael Kauffman in Karyopharm Therapeutics Inc.

Trading Symbol: KPTI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Kauffman: Chief Executive Officer
Holdings: 714,826 shares
Current Value: $7,377,004
Latest Transaction: Mar 23 2021
$KPTI Market Capitalization: $416.55M
$KPTI Previous Close: $10.32

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Michael Kauffman in Karyopharm Therapeutics Inc.

Sentiment: All, CRXX, INFI, KPTI, KZR, VSTM

Page: < prev 1 2

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Aug 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	12,500	413	726,010	713.5 K to 726 K (+1.75 %)
Jul 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	4.75	4,242	20,158	476,061
Jul 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	5,757	1,520	0
Jul 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	1	0	0
Jul 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	18.27	10,000	182,686	512,143	522.1 K to 512.1 K (-1.92 %)
Jul 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	4.75	4,242	20,158	522,143	517.9 K to 522.1 K (+0.82 %)
Jul 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	5,757	1,520	517,901	512.1 K to 517.9 K (+1.12 %)
Jul 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	1	0	512,144	512.1 K to 512.1 K (0.00 %)
Jul 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	12,500	413	26,764
Jul 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	18.72	12,500	233,990	713,510	726 K to 713.5 K (-1.72 %)
Jul 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	12,500	413	726,010	713.5 K to 726 K (+1.75 %)
Jun 19 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	10,000	2,640	5,757
Jun 19 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	18.66	10,000	186,558	512,143	522.1 K to 512.1 K (-1.92 %)
Jun 19 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	522,143	512.1 K to 522.1 K (+1.95 %)
Jun 11 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.03	303	10	7,553
Jun 11 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	9,697	2,560	0
Jun 11 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	17.30	10,000	172,991	713,510	723.5 K to 713.5 K (-1.38 %)
Jun 11 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.03	303	10	723,510	723.2 K to 723.5 K (+0.04 %)
Jun 11 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	9,697	2,560	723,207	713.5 K to 723.2 K (+1.36 %)
May 21 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	10,000	2,640	15,757
May 21 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	19.39	10,000	193,870	512,143	522.1 K to 512.1 K (-1.92 %)
May 21 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	522,143	512.1 K to 522.1 K (+1.95 %)
May 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	10,000	2,640	9,697
May 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	16.77	10,000	167,747	713,510	723.5 K to 713.5 K (-1.38 %)
May 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	723,510	713.5 K to 723.5 K (+1.40 %)
Apr 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	7,576	2,000	18,181
Apr 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	2,424	640	0
Apr 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	14.79	10,000	147,878	512,143	522.1 K to 512.1 K (-1.92 %)
Apr 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	522,143	512.1 K to 522.1 K (+1.95 %)
Apr 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	10,000	2,640	19,697
Apr 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	12.48	10,000	124,829	713,510	723.5 K to 713.5 K (-1.38 %)
Apr 10 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	723,510	713.5 K to 723.5 K (+1.40 %)
Mar 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	10,000	2,640	2,424
Mar 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	15.29	10,000	152,895	512,143	522.1 K to 512.1 K (-1.92 %)
Mar 20 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	522,143	512.1 K to 522.1 K (+1.95 %)
Mar 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	606	160	29,697
Mar 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	9,394	2,480	0
Mar 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	16.15	10,000	161,463	713,510	723.5 K to 713.5 K (-1.38 %)
Mar 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	723,510	713.5 K to 723.5 K (+1.40 %)
Feb 22 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	10,000	2,640	12,424
Feb 22 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	14.79	10,000	147,872	512,143	522.1 K to 512.1 K (-1.92 %)
Feb 22 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	522,143	512.1 K to 522.1 K (+1.95 %)
Feb 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	10,000	2,640	9,394
Feb 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	12.50	10,000	125,048	713,510	723.5 K to 713.5 K (-1.38 %)
Feb 08 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	723,510	713.5 K to 723.5 K (+1.40 %)
Jan 25 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	10.45	200,000	2,090,000	200,000
Jan 25 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	10.45	200,000	2,090,000	200,000
Jan 22 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	10,000	2,640	22,424
Jan 22 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	10.09	10,000	100,882	512,143	522.1 K to 512.1 K (-1.92 %)
Jan 22 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	522,143	512.1 K to 522.1 K (+1.95 %)
Jan 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	10,000	2,640	19,394
Jan 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	10.08	10,000	100,769	713,510	723.5 K to 713.5 K (-1.38 %)
Jan 09 2018	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	723,510	713.5 K to 723.5 K (+1.40 %)
Dec 20 2017	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	10,000	2,640	32,424
Dec 20 2017	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	9.16	10,000	91,553	512,143	522.1 K to 512.1 K (-1.92 %)
Dec 20 2017	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	522,143	512.1 K to 522.1 K (+1.95 %)
Dec 08 2017	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	M	0.26	10,000	2,640	29,394
Dec 08 2017	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Sell	S	10.39	10,000	103,903	713,510	723.5 K to 713.5 K (-1.38 %)
Dec 08 2017	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Buy	M	0.26	10,000	2,640	723,510	713.5 K to 723.5 K (+1.40 %)
Jan 24 2017	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	10.39	250,000	2,597,500	250,000
Jan 24 2017	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	10.39	250,000	2,597,500	250,000
Jan 20 2016	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	6.54	170,000	1,111,800	170,000
Jan 20 2016	KPTI	Karyopharm Therape ...	Kauffman Michael	Chief Executive Off ...	Option Exercise	A	6.54	170,000	1,111,800	170,000

Page: < prev 1 2